Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Head-to-head data are sparse
In studies involving delicate cellular systems or tissue samples, this solution is particularly valuable for ensuring the accuracy of dilution processes and maintaining consistency across experimental replicates
Ongoing trials Trials like NCT07328100 (intravenous coenzyme I for vascular aging, 2026 start) and NCT05243290 (oral NR in Gulf War Illness) continue to expand the human evidence base
Regular Treatments : You may need to get these injections regularly, depending on your plan
US$ 22.51
US$ 23.33
US$ 20.84
US$ 27.68
US$ 27.30
US$ 26.25
US$ 29.17
US$ 25.98
US$ 21.80
US$ 23.88
![Efficacy of tirzepatide in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1](https://www.researchgate.net/publication/363201315/figure/fig3/AS:11431281082605778@1662084799021/Efficacy-of-tirzepatide-in-phase-2-GPGB-14-and-phase-3-SURPASS-1-to-5-15-19.png)